AKZA Stock Analysis: Akzo Nobel | AS
Specialty Chemicals | AS, Netherlands | Market Cap: 9.729m EUR | 12M Return: 1.4% | NL0013267909 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.0M
EPS Trend: 58.5%
Qual. Beats: 0
Rev. Trend: -86.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Akzo Nobel N.V. is a Dutch global producer of paints and coatings, organized into two main segments: Decorative Paints and Performance Coatings. The decorative paints business supplies paints, enamels, varnishes, surface preparation products, mixing machines, color concepts, and applicator training, while the performance coatings segment delivers engineered coatings with functional properties such as corrosion and fouling control, anti-scratch performance, and fire protection for ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. The company markets its products under an extensive portfolio of well-known brands, including Dulux, Sikkens, International, Interpon, Hammerite, Cuprinol, and Taubmans, among many others.
Akzo Nobel serves a diversified end-market mix spanning energy, packaging, infrastructure, shipbuilding and maintenance, and a broad set of general industrial applications such as agricultural and construction equipment, construction-related steel, metal fabrication, pipes, appliances, and transportation. The company is classified within the GICS Specialty Chemicals sub-industry, reflecting its formulation-driven, brand-led business model that combines consumer-facing decorative products with technically specified industrial coatings. As a large-cap materials company, its revenue is closely tied to cyclical drivers such as construction activity, automotive production, and global industrial output.
Founded in 1646 and headquartered in Amsterdam, the Netherlands, Akzo Nobel was formerly known as Akzo NV before adopting its current name in 1994, giving it one of the longest corporate histories in the chemicals and coatings industry.
- Titanium dioxide cost volatility pressures decorative paints margins
- European construction slowdown weighs on decorative paint volumes
- Marine and aerospace coatings demand recovers from cyclical lows
| Net Income: 636.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.49 > 1.0 |
| NWC/Revenue: 38.52% < 20% (prev 11.10%; Δ 27.42% < -1%) |
| CFO/TA 0.06 > 3% & CFO 911.0m > Net Income 636.0m |
| Net Debt (3.40b) to EBITDA (1.65b): 2.06 < 3 |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (171.4m) vs 12m ago -0.48% < -2% |
| Gross Margin: 40.70% > 18% (prev 39.85%; Δ 0.85% > 0.5%) |
| Asset Turnover: 65.30% > 50% (prev 74.28%; Δ -8.98% > 0%) |
| Interest Coverage Ratio: 7.0 > 6 (EBIT TTM 1.27b / Interest Expense TTM 182.0m) |
| A: 0.24 (Total Current Assets 8.12b - Total Current Liabilities 4.31b) / Total Assets 16.1b |
| B: 0.33 (Retained Earnings 5.36b / Total Assets 16.1b) |
| C: 0.08 (EBIT TTM 1.27b / Avg Total Assets 15.2b) |
| D: 0.44 (Book Value of Equity 4.85b / Total Liabilities 11.1b) |
| Altman-Z'' = 3.66 = AA |
| DSRI: 1.09 (Receivables 2.90b/2.82b, Revenue 9.89b/10.5b) |
| GMI: 0.98 (GM 39.85% / 40.70%) |
| AQI: 0.89 (AQ_t 0.35 / AQ_t-1 0.39) |
| SGI: 0.94 (Revenue 9.89b / 10.5b) |
| TATA: -0.02 (NI 636.0m - CFO 911.0m) / TA 16.1b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of October 07, 2026, the stock is trading at EUR 58.76 with a total of 685,938 shares traded. Over the past week, the price has changed by +3.52%, over one month by -2.33%, over three months by -1.57% and over the past year by +1.44%.
Current recommended Stop Loss: 57.20 (which is 2.7% or 1.2 ATR below the current price).
Akzo Nobel has no consensus analysts rating.
P/E Trailing = 15.2581
P/E Forward = 13.459
P/S = 0.9833
P/B = 2.0146
P/EG = 2.1698
Revenue TTM = 9.89b EUR
EBIT TTM = 1.27b EUR
EBITDA TTM = 1.65b EUR
Long Term Debt = 5.50b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.09b EUR (from shortTermDebt, last quarter)
Debt = 6.87b EUR (from shortLongTermDebtTotal, last quarter) + Leases 274.0m
Net Debt = 3.40b EUR (calculated: Debt 6.87b - CCE 3.46b)
Enterprise Value = 13.1b EUR (9.73b + Debt 6.87b - CCE 3.46b)
Interest Coverage Ratio = 7.0 (Ebit TTM 1.27b / Interest Expense TTM 182.0m)
EV/FCF = 21.01x (Enterprise Value 13.1b / FCF TTM 625.0m)
FCF Yield = 4.76% (FCF TTM 625.0m / Enterprise Value 13.1b)
FCF Margin = 6.32% (FCF TTM 625.0m / Revenue TTM 9.89b)
Net Margin = 6.43% (Net Income TTM 636.0m / Revenue TTM 9.89b)
Gross Margin = 40.70% ((Revenue TTM 9.89b - Cost of Revenue TTM 5.87b) / Revenue TTM)
Gross Margin QoQ = 41.95% (prev 40.99%)
Tobins Q-Ratio = 0.81 (Enterprise Value 13.1b / Total Assets 16.1b)
Interest Expense / Debt = 2.65% (Interest Expense 182.0m / Debt 6.87b)
Taxrate = 34.32% (348.0m / 1.01b)
NOPAT = 836.8m (EBIT 1.27b * (1 - 34.32%))
Current Ratio = 1.88 (Total Current Assets 8.12b / Total Current Liabilities 4.31b)
Debt / Equity = 1.41 (Debt 6.87b / totalStockholderEquity, last quarter 4.85b)
Debt / EBITDA = 2.06 (Net Debt 3.40b / EBITDA 1.65b)
Debt / FCF = 5.44 (Net Debt 3.40b / FCF TTM 625.0m)
Total Stockholder Equity = 4.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.20% (Net Income 636.0m / Total Assets 16.1b)
RoE = 13.88% (Net Income TTM 636.0m / Total Stockholder Equity 4.58b)
RoCE = 12.64% (EBIT 1.27b / Capital Employed (Equity 4.58b + L.T.Debt 5.50b))
RoIC = 6.74% (NOPAT 836.8m / Invested Capital 12.4b)
WACC = 5.12% (E(9.73b)/V(16.6b) * Re(7.51%) + D(6.87b)/V(16.6b) * Rd(2.65%) * (1-Tc(0.34)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 22.33 | Cagr: 0.21%
[DCF] Terminal Value 77.97% ; FCFF base≈567.0m ; Y1≈650.0m ; Y5≈956.6m
[DCF] Fair Price = 64.14 (EV 14.4b - Net Debt 3.40b = Equity 11.0b / Shares 171.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 58.48 | EPS CAGR: 6.19% | SUE: -0.68 | # QB: 0
Revenue Correlation: -86.26 | Revenue CAGR: -2.83% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.04 | Chg30d=-1.90% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=3.88 | Chg30d=-0.32% | Revisions=+24% | GrowthEPS=+7.0% | GrowthRev=-1.2%
EPS next Year (2027-12-31): EPS=4.28 | Chg30d=-0.55% | Revisions=+31% | GrowthEPS=+10.3% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: +34% (up=20, down=9)